Meyka Pro banner
Amarin Corporation plc

Amarin Corporation plc (AMRN) Stock Overview

Explore Amarin Corporation plc’s financial performance, market position, analyst ratings, and future outlook.

AMRNNASDAQ
HealthcareDrug Manufacturers - General
$13.97
$0.10(0.71%)
U.S. Market opens in 1h 25m

Amarin Corporation plc (AMRN)

Meyka AI Score

Z

Key Financials

Market Cap288.9M
P/E Ratio-9.75
EPS (TTM)$-0.10
ROE-0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$12.74
3 Months$5.85
1 Year Target$21.18

AMRN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Amarin Corporation plc (NASDAQ: AMRN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Amarin Corporation plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AMRN on the NASDAQ shows an RSI of 45.62, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $21.18 for the NASDAQ listing.

Key metrics behind Amarin Corporation plc's NASDAQ-traded stock include a P/E ratio of -9.75 and a market capitalization of 288.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMRN on the NASDAQ.

Price Performance (NASDAQ: AMRN)

1-Day Change
-0.71%
5-Day Change
-0.50%
1-Month Change
0.14%
3-Month Change
-3.05%
6-Month Change
1.23%
Year-to-Date (YTD) Change
0.07%
1-Year Change
-9.34%
3-Year Change
-32.84%
5-Year Change
-87.39%
All-Time (Max) Change
-99.88%

Contact Information

353 1 669 9020
One Central Plaza, Dublin, DU, D02 K7K5

Company Facts

800 Employees
IPO DateApr 1, 1993
CountryIE
Actively Trading

Frequently Asked Questions